Zhuhai Rundu Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
Zhuhai Rundu Pharmaceutical has a total shareholder equity of CN¥1.1B and total debt of CN¥504.7M, which brings its debt-to-equity ratio to 43.9%. Its total assets and total liabilities are CN¥2.2B and CN¥1.0B respectively. Zhuhai Rundu Pharmaceutical's EBIT is CN¥41.7M making its interest coverage ratio 2.9. It has cash and short-term investments of CN¥190.1M.
Key information
43.9%
Debt to equity ratio
CN¥504.71m
Debt
| Interest coverage ratio | 2.9x |
| Cash | CN¥190.14m |
| Equity | CN¥1.15b |
| Total liabilities | CN¥1.02b |
| Total assets | CN¥2.17b |
Recent financial health updates
No updates
Recent updates
Zhuhai Rundu Pharmaceutical's (SZSE:002923) Dividend Is Being Reduced To CN¥0.20
May 29
There May Be Reason For Hope In Zhuhai Rundu Pharmaceutical's (SZSE:002923) Disappointing Earnings
May 05There's Reason For Concern Over Zhuhai Rundu Pharmaceutical Co., Ltd.'s (SZSE:002923) Massive 32% Price Jump
Mar 05Financial Position Analysis
Short Term Liabilities: 002923's short term assets (CN¥837.1M) exceed its short term liabilities (CN¥440.4M).
Long Term Liabilities: 002923's short term assets (CN¥837.1M) exceed its long term liabilities (CN¥575.8M).
Debt to Equity History and Analysis
Debt Level: 002923's net debt to equity ratio (27.4%) is considered satisfactory.
Reducing Debt: 002923's debt to equity ratio has increased from 3.7% to 43.9% over the past 5 years.
Debt Coverage: 002923's debt is well covered by operating cash flow (46.1%).
Interest Coverage: 002923's interest payments on its debt are not well covered by EBIT (2.9x coverage).